A-003 - PDFSEARCH.IO - Document Search Engine

A-003
Results: 302

#	Item
31	1_ORG_A_003_Dienstleistungsübersicht_D_2013-09-01 Add to Reading List Source URL: www.hbi.ch Language: German - Date: 2013-10-14 05:13:00
32	Microsoft Word - a_2005-003.doc Add to Reading List Source URL: ais.ans.cz Language: English - Date: 2015-01-19 04:21:38
33	GENERAL TERMS AND CONDITIONS OF SALE AND DELIVERY SETTALA GAS S.P.A. Release: 003-‐2013 valid from Settala Gas S.p.A. Add to Reading List Source URL: www.settalagas.it Language: English - Date: 2015-05-03 10:34:31
34	No. SSI-ICP-003 Spectrophotometric Analysis Analysis of Highly Mineralized Aqueous Solutions by ICP-AES, a Non-dilution Method with Multi-wavelength Add to Reading List Source URL: www.ssi.shimadzu.com Language: English - Date: 2016-05-31 09:19:31
35	Updated immunologic and clinical results from a phase 2 study of AGS-003, an autologous dendritic cell based therapy, in patients with newly diagnosed metastatic renal cell carcinoma in combination with sunitinib. R. A. Add to Reading List Source URL: www.argostherapeutics.com Language: English - Date: 2013-12-05 12:55:52
36	A PHASE 1/2 STUDY OF AGS-003, A PERSONALIZED IMMUNOTHERAPEUTIC EVALUATED IN NEWLY DIAGNOSED METASTATIC RENAL CELL CARCINOMA SUBJECTS T. Logan1, A. Amin2, V. Cohen3, M. K. K. Wong4, V. A. Master5, T. Monesmith6, D. Healey Add to Reading List Source URL: www.argostherapeutics.com Language: English - Date: 2013-12-05 12:55:33
37	Session Time: Poster Session Session Number: 003 Session Title: Poster Session 1 Poster Presentation Time: Monday, February 8, 2016, 11:30 am - 1:00 pm Topic: A. Viral Agents Add to Reading List Source URL: asmbiodefense.org Language: English - Date: 2016-02-02 10:17:32
38	Session Time: Poster Session Session Number: 003 Session Title: Poster Session 1 Poster Presentation Time: Monday, February 8, 2016, 11:30 am - 1:00 pm Topic: A. Viral Agents Add to Reading List Source URL: www.asmbiodefense.org Language: English - Date: 2016-02-02 10:17:32
39	Monitoring T cell responses in a phase II study of AGS-003, an autologous dendritic cell based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib. R. A. Figlin1, A. Add to Reading List Source URL: www.argostherapeutics.com Language: English - Date: 2013-12-05 12:55:49
40	A phase II study testing the safety and activity of AGS-003 as an immunotherapeutic in subjects with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib A. Amin1, A. Z. Dudek2, T. Logan3, R. Add to Reading List Source URL: www.argostherapeutics.com Language: English - Date: 2013-12-05 12:55:31

UPDATE